EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Fecal tryptophan metabolite profiling in newborns in relation to microbiota and antibiotic treatment

Anne-Christine Aust, Veronika Vidova, Katerina Coufalikova, Sona Smetanova, Kristyna Kozeluhova, Lenka Micenkova, Petra Videnska, Stanislav Smatana, Eva Budinska, Ivo Borek, Petr Janku, Jana Klanova und 2 weitere

Applied Microbiology and Biotechnology · 2024

DOI: 10.1007/s00253-024-13339-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Applied Microbiology and Biotechnology, 2024. Verfasst von Anne-Christine Aust und 13 weiteren Autor:innen. Beteiligte Einrichtung: RECETOX, Faculty of Science, Masaryk University, Kamenice 753/5, pavilion D29/1S101, 625 00, Brno, Czech Republic. Hauptthemen laut MEDLINE: Feces, Tryptophan, Anti-Bacterial Agents, Gastrointestinal Microbiome. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerstvo Školství, Mládeže a Tělovýchovy, Ministerstvo Zdravotnictví Ceské Republiky, HORIZON EUROPE Research Infrastructures.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In the first days of life, the newborns’ intestinal microbiota develops simultaneously with the intestinal gut barrier and follows intestinal immunity. The mode of delivery shows significant impact on microbial development and, thus, the initiation of the tryptophan catabolism pathway. Further antibiotics (ATB) treatment of mothers before or during delivery affects the microbial and tryptophan metabolite composition of stool of the caesarean- and vaginal-delivered newborns. The determination of microbiome and levels of tryptophan microbial metabolites in meconium and stool can characterize intestinal colonization of a newborn. From 134 samples from the Central European Longitudinal Studies of Parents and Children: The Next Generation (CELSPAC: TNG) cohort study, 16S rRNA gene sequencing was performed, and microbial tryptophan metabolites were quantified using ultra-high-performance liquid chromatography with triple-quadrupole mass spectrometry. Microbial diversity and concentrations of tryptophan metabolites were significantly higher in stool compared to meconium. Treatment of mothers with ATB before or during delivery affects metabolite composition and microbial diversity in stool of vaginal- and caesarean-delivered newborns. Correlation of microbial and metabolite composition shows significant positive correlations of indol-3-lactic acid, N -acetyl-tryptophan and indol-3-acetic acid with Bifidobacterium , Bacteroides and Peptoclostridium . The positive effect of vaginal delivery on newborns’ microbiome development is degraded when mother is treated with ATB before or during delivery. Key points • Antibiotic treatment diminishes the positive effects of vaginal delivery. • Antibiotic treatment affects metabolite and microbial composition in newborns. • Bifidobacterium and Peptoclostridium could be the producer of indole-lactic acid.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FecesTryptophanAnti-Bacterial AgentsGastrointestinal MicrobiomeRNA, Ribosomal, 16SMeconiumHumansInfant, NewbornFemaleIndolesIndoleacetic AcidsChromatography, High Pressure LiquidLongitudinal StudiesBifidobacterium

Stichwörter der Autor:innen

Caesarean deliveryKynurenineMicrobiomeStoolTryptophan catabolitesVaginal delivery

Substanzen

TryptophanAnti-Bacterial AgentsRNA, Ribosomal, 16SIndolesindole-3-lactic acidindoleacetic acidIndoleacetic Acids

Autor:innen und Institutionen

  • RECETOX, Faculty of Science, Masaryk University, Kamenice 753/5, pavilion D29/1S101, 625 00, Brno, Czech Republic.
  • Department of Neonatology, University Hospital Brno, Brno, Czech Republic.
  • Clinic of Gynecology and Obstetrics, University Hospital Brno, Brno, Czech Republic.
  • RECETOX, Faculty of Science, Masaryk University, Kamenice 753/5, pavilion D29/1S101, 625 00, Brno, Czech Republic. vojtech.thon@recetox.muni.cz.

Förderung

  • Ministerstvo Školství, Mládeže a Tělovýchovy
  • Ministerstvo Zdravotnictví Ceské Republiky
  • HORIZON EUROPE Research Infrastructures

Zitieren

APA

Aust, A. C., Vidova, V., Coufalikova, K., Smetanova, S., Kozeluhova, K., Micenkova, L., Videnska, P., Smatana, S., Budinska, E., Borek, I., Janku, P., Klanova, J., Spacil, Z., & Thon, V. (2024). Fecal tryptophan metabolite profiling in newborns in relation to microbiota and antibiotic treatment. Applied Microbiology and Biotechnology. https://doi.org/10.1007/s00253-024-13339-4

Vancouver

Aust AC, Vidova V, Coufalikova K, Smetanova S, Kozeluhova K, Micenkova L, et al. Fecal tryptophan metabolite profiling in newborns in relation to microbiota and antibiotic treatment. Applied Microbiology and Biotechnology. 2024. doi:10.1007/s00253-024-13339-4

BibTeX
@article{Aust2024,
  author = {Aust, Anne-Christine and Vidova, Veronika and Coufalikova, Katerina and Smetanova, Sona and Kozeluhova, Kristyna and Micenkova, Lenka and Videnska, Petra and Smatana, Stanislav and Budinska, Eva and Borek, Ivo and Janku, Petr and Klanova, Jana and Spacil, Zdenek and Thon, Vojtech},
  title = {Fecal tryptophan metabolite profiling in newborns in relation to microbiota and antibiotic treatment},
  journal = {Applied Microbiology and Biotechnology},
  year = {2024},
  doi = {10.1007/s00253-024-13339-4}
}
Kostenlos starten →